Literature DB >> 2363705

Evidence for reverse cholesterol transport in vivo from liver endothelial cells to parenchymal cells and bile by high-density lipoprotein.

H F Bakkeren1, F Kuipers, R J Vonk, T J Van Berkel.   

Abstract

Acetylated low-density lipoprotein (acetyl-LDL), biologically labelled in the cholesterol moiety of cholesteryl oleate, was injected into control and oestrogen-treated rats. The serum clearance, the distribution among the various lipoproteins, the hepatic localization and the biliary secretion of the [3H]cholesterol moiety were determined at various times after injection. In order to monitor the intrahepatic metabolism of the cholesterol esters of acetyl-LDL in vivo, the liver was subdivided into parenchymal, endothelial and Kupffer cells by a low-temperature cell-isolation procedure. In both control and oestrogen-treated rats, acetyl-LDL is rapidly cleared from the circulation, mainly by the liver endothelial cells. Subsequently, the cholesterol esters are hydrolysed, and within 1 h after injection, about 60% of the cell- associated cholesterol is released. The [3H]cholesterol is mainly recovered in the high-density lipoprotein (HDL) range of the serum of control rats, while low levels of radioactivity are detected in serum of oestrogen-treated rats. In control rats cholesterol is transported from endothelial cells to parenchymal cells (reverse cholesterol transport), where it is converted into bile acids and secreted into bile. The data thus provide evidence that HDL can serve as acceptors for cholesterol from endothelial cells in vivo, whereby efficient delivery to the parenchymal cells and bile is assured. In oestrogen-treated rats the radioactivity from the endothelial cells is released with similar kinetics as in control rats. However, only a small percentage of radioactivity is found in the HDL fraction and an increased uptake of radioactivity in Kupffer cells is observed. The secretion of radioactivity into bile is greatly delayed in oestrogen-treated rats. It is concluded that, in the absence of extracellular lipoproteins, endothelial cells can still release cholesterol, although for efficient transport to liver parenchymal cells and bile, HDL is indispensable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363705      PMCID: PMC1131494          DOI: 10.1042/bj2680685

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Processing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin?

Authors:  T J Van Berkel; J F Nagelkerke; L Harkes; J K Kruijt
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

2.  Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells.

Authors:  H Funke; J Boyles; K H Weisgraber; E H Ludwig; D Y Hui; R W Mahley
Journal:  Arteriosclerosis       Date:  1984 Sep-Oct

3.  Up-regulation in vascular endothelial cells of binding sites of high density lipoprotein induced by 25-hydroxycholesterol.

Authors:  J P Tauber; D Goldminz; D Gospodarowicz
Journal:  Eur J Biochem       Date:  1981-10

Review 4.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

5.  In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.

Authors:  J F Nagelkerke; K P Barto; T J van Berkel
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

6.  Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.

Authors:  Y S Chao; E E Windler; G C Chen; R J Havel
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

7.  Clearance of acetyl low density lipoprotein by rat liver endothelial cells. Implications for hepatic cholesterol metabolism.

Authors:  R Blomhoff; C A Drevon; W Eskild; P Helgerud; K R Norum; T Berg
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

8.  Cellular localization of the receptor-dependent and receptor-independent uptake of human LDL in the liver of normal and 17 alpha-ethinyl estradiol-treated rats.

Authors:  L Harkes; T J van Berkel
Journal:  FEBS Lett       Date:  1983-04-05       Impact factor: 4.124

9.  The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters.

Authors:  M S Brown; Y K Ho; J L Goldstein
Journal:  J Biol Chem       Date:  1980-10-10       Impact factor: 5.157

10.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins.

Authors:  M S Brown; J L Goldstein; M Krieger; Y K Ho; R G Anderson
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539

View more
  3 in total

1.  Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters.

Authors:  M N Pieters; G R Castro; D Schouten; P Duchateau; J C Fruchart; T J Van Berkel
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

2.  Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis.

Authors:  M N Pieters; D Schouten; H F Bakkeren; B Esbach; A Brouwer; D L Knook; T J van Berkel
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

3.  Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice.

Authors:  Prakash Doddapattar; Branislav Radović; Jay V Patankar; Sascha Obrowsky; Katharina Jandl; Christoph Nusshold; Dagmar Kolb; Nemanja Vujić; Lalit Doshi; Prakash G Chandak; Madeleine Goeritzer; Helmut Ahammer; Gerald Hoefler; Wolfgang Sattler; Dagmar Kratky
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.